Results 111 to 120 of about 39,988 (211)

Neuroinflammatory and Motor Alterations in LRRK2*G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP-Induced Nigrostriatal Neurodegeneration. [PDF]

J Neurochem
García-Swinburn R, Morón-Márquez L, Conde-Naranjo C, García-Roldán E, Espadas I, Rodríguez-Gil A, Ramírez-Lorca R, Villadiego J, Toledo-Aral JJ.   +8 more
europepmc   +1 more source

Transcriptome Sequencing Reveals Molecular Characteristics of Spinal Cord Degeneration in MPTP-Induced Parkinson's Disease Mice. [PDF]

Biology (Basel)
Xiao L, Wu Y, Huang X, Deng H, Wu Y, Pan W, Wang W, Wang M.   +7 more
europepmc   +1 more source

Corrected Version: Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease. [PDF]

J Clin Exp Immunol
Chandra G, Rangasamy SB, Pahan K.
europepmc   +1 more source

RETRACTED: Atiq et al. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 9942. [PDF]

Int J Mol Sci
Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS, Kim MO.   +10 more
europepmc   +1 more source

Mitochondrial remodeling in heart failure with reduced ejection fraction. [PDF]

Front Physiol
Chen X.
europepmc   +1 more source

Nigral biochemical and structural alterations following subacute exposure to MPTP in mice. [PDF]

Toxicol Rep
Henry R, Agbon AN, Musa SA, Oladele SB.
europepmc   +1 more source

<i>Lactobacillus reuteri</i> DSM 17938 and Its Supernatant Ameliorate Parkinson's Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism. [PDF]

Antioxidants (Basel)
Su B, Meng F, Lu Y, Zhang Y, Wang T, Zhang Y, Liu J, Lin L.   +7 more
europepmc   +1 more source

Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets

Objective Establishment of preclinical method evaluating behavioral protective actions of drugs for Parkinsons disease was attempted by using l-deprenyl (DEP) as a reference drug in MPTP-treated common marmosets.
447750, Inaji, Motoki, 447753, Maeda, Jun, Andou, Kiyoshi, et.al, 447751, 447752, 447746, Obayashi, Shigeru, 447747, 稲次 基希, 447744, Suhara, Tetsuya, 447745, 前田 純, 447748, 447749, 安東 潔, Okauchi, Takashi, 樋口 真人, 須原 哲也, 岡内 隆, Higuchi, Makoto, 447742, 447743, 447740, 447741, 447739, 大林 茂   +29 more
core  

Ceftriaxone's Multifaceted Neuroprotection in Parkinson's Disease: Preclinical Evidence and Implications for Drug Repurposing. [PDF]

Drug Des Devel Ther
Wen P, Dou L, Yang X, Han D, Wang J, Wu H, Ren C.   +6 more
europepmc   +1 more source